Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 6 Finished
-
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
Wang, J. (PI), Woyach, J. A. (CoPI) & Wang, M. M. (CoPI)
07/1/20 → 06/30/25
Project: Research
-
Improving BTK Directed Therapy for CLL
Woyach, J. A. (PI) & Johnson, A. J. (CoPI)
07/1/15 → 06/30/21
Project: Research
-
Dual targeting of XPO1 and BTK in B cell malignancies
Lapalombella, R. (PI), Blum, K. A. (CoPI), Byrd, J. C. (CoPI) & Woyach, J. A. (CoPI)
04/21/15 → 03/31/21
Project: Research
-
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
Byrd, J. C. (PI), Johnson, A. J. (CoPI) & Woyach, J. A. (CoPI)
01/1/14 → 12/31/19
Project: Research
-
Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia
Woyach, J. A. (PI)
09/17/13 → 08/31/18
Project: Research
-
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Alsouqi, A., Huang, Y., Christian, B., Reneau, J., Bhat, S. A., Brammer, J., Sawalha, Y., Baiocchi, R. A., Grever, M., Rogers, K. A., Reeser, J., Smith, A., Samorodnitsky, E., Roychowdhury, S., Maddocks, K., Woyach, J. A. & Bond, D., Mar 2026, In: European Journal of Haematology. 116, 3, p. 326-329 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026 Featured Updates to the NCCN Guidelines
Wierda, W. G., Brown, J., Abramson, J. S., Awan, F., Bociek, G., Boyer, D., Cortese, M., Cripe, L., D’angelo, C., Darnell, E., Davis, R. S., Eradat, H., Esteghamat, N., Fitzgerald, L., Fletcher, C. D., Gaballa, S., Huntington, S., Kahl, B., Kamdar, M. & Kipps, T. J. & 17 others, , Mar 1 2026, In: JNCCN Journal of the National Comprehensive Cancer Network. 24, 3, p. 68-80 13 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia
Zhang, L., Han, Q., Xiang, H., Lapalombella, R., Eisfeld, A. K., Hanel, W. G., Brammer, J. E., Mims, A. S., Woyach, J. A., Song, C. & Ge, Z., Apr 2026, In: Leukemia. 40, 4, p. 794-805 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia
Brown, J. R., Nguyen, B., Desikan, S. P., Won, H., Tantawy, S. I., McNeely, S. C., Marella, N., Randeria, H. S., Hanson, L. M., Parker, A., Botelho, S. C., Woyach, J. A., Patel, K., Tam, C. S., Eyre, T. A., Cheah, C. Y., Shah, N. N., Ghia, P., Jurczak, W. & Balbas, M. & 7 others, , Jan 1 2026, In: Blood. 147, 1, p. 24-34 11 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study
Patel, K., Vose, J. M., Nasta, S. D., Brown, J. R., Maddocks, K. J., Woyach, J. A., Shah, N. N., Fakhri, B., Tessoulin, B., Ma, S., Jagadeesh, D., Lech-Maranda, E., Coombs, C. C., Patel, M. R., Rhodes, J. M., Ujjani, C., Hoffmann, M. S., Cheah, C. Y., Munir, T. & Lewis, D. & 11 others, , Apr 14 2026, In: Blood Advances. 10, 7, p. 2441-2451 11 p.Research output: Contribution to journal › Article › peer-review
Open Access